Online program to help young female cancer survivors with sexual health issues
Sexual Health and Rehabilitation Online (SHAREonline): An Educational Intervention for Young Adult Women After Cancer
This study tests whether a group education session or a one-on-one self-management session can better help young female cancer survivors deal with sexual health issues.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 84 (estimated) |
| Ages | 19 Years to 49 Years |
| Sex | Female |
| Sponsor | Dana-Farber Cancer Institute Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06458049 on ClinicalTrials.gov |
What this trial studies
SHAREonline is designed for young female cancer survivors experiencing changes in sexual health and function. The study compares two brief interventions delivered via videoconference: a group education session and an individual self-management session. Participants will first complete health questionnaires and then be randomized to one of the two intervention types. The goal is to determine which approach is more effective in helping women manage their sexual health concerns and restore sexual functioning.
Who should consider this trial
Good fit: Ideal candidates are female cancer survivors aged 19-49 who have experienced significant sexual dysfunction after their cancer treatment.
Not a fit: Patients who have never been sexually active or have impairments that prevent them from completing study procedures independently may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the sexual health and quality of life for young female cancer survivors.
How similar studies have performed: Other studies have shown promise in using online interventions for sexual health issues, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
* Female cancer survivors age 19-49 * Cancer diagnosis (except non-melanoma skin cancer) ≥ 1 year prior * Diagnosed with first cancer ≥ age 18 * No active cancer therapy (excluding chemoprevention) in the past four months, and no further therapy planned * Ability to read and write in English * Bothered by significant sexual dysfunction as evidenced by a Female Sexual Functioning Index (FSFI) score of ≤26. * Regular access to the internet Exclusion Criteria * Has never been sexually active * Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently
Where this trial is running
Boston, Massachusetts
- Dana Farber Cancer Institute — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Sharon Bober, PhD — Dana-Farber Cancer Institute
- Study coordinator: Sharon Bober, PhD
- Email: share@dfci.harvard.edu
- Phone: 617-632-6547
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.